IAAF 2017 IAAF vs Suleiman Kipses Simotwo

IAAF 2017 IAAF vs Suleiman Kipses Simotwo
February 27, 2018

In July 2017 the IAAF Athletics Integrity Unit (AIU) has reported an anti-doping rule violation against the Kenyan Athlete Suleiman Kipses Simotwo after his sample tested positive for the prohibited substance 19-norandrosterone (Nandrolone). After notification a provisional suspension was ordered. The Athlete filed a statement in his defence and was heard for the IAAF Disciplinary Tribunal Panel.

The Athlete denied the intentional use of the substance and stated that he was tested before without issues.
He suggested that something may have happened when he was in a district hospital in December 2016. He testified that he became unconscious and suffered an injury due to a fall in the bath. In the hospital he underwent treatment and left it with some medication.
The AIU contended that the Athlete statement did not explain his positive test about 4 months later.

The Panel finds that the Athlete failed to establish how the substance entered his system nor did he demonstrate with evidence that his hospital treatment in December 2016 caused the positive test result.

The Panel concludes that het evidence establish that the Athlete has committed the anti-doping rule violation without grounds for a reduced sanction.

Therefore the IAAF Disciplinary Tribunal Panel decides on 27 February 2018 to impose a 4 year period on the Athlete, starting on the date of the provisional suspension, i.e. on 14 July 2017.

show »
Type:
pdf

Parameters:

Legal
Decisions International Federations
Date:
27 February 2018
Arbitrator
Beloff, Michael J.
Source
Anti-Doping Agency of Kenya (ADAK)
Country
Kenya
Language
English
ADRV
Adverse Analytical Finding
Legal Terms
Burdens and standards of proof
Sole Arbitrator
Sport/IFs
Athletics (IAAF) - International Association of Athletics Federations
Other organisations
Anti-Doping Agency of Kenya (ADAK)
Laboratories
Seibersdorf, Austria: Seibersdorf Labor GmbH Doping Control Laboratory
Doping classes
S1. Anabolic Agents
Substances
19-norandrosterone
Nandrolone
Medical terms
Treatment
Document type
pdf
Category
  • Legal
  • Education
  • Science
  • Statistics
  • History
Country & language
  • Country
  • Language
Other filters
  • ADRV
  • Legal Terms
  • Sport/IFs
  • Other organisations
  • Laboratories
  • Analytical aspects
  • Doping classes
  • Substances
  • Medical terms
  • Various
  • Version
  • Document category
  • Document type
Publication period
Origin